West Pharmaceutical Services | WST - Cost Of Sales

Stock Price
248.95
Daily Change
17.33 7.48%
Monthly
-10.59%
Yearly
-22.58%
Q1 Forecast
224.00

West Pharmaceutical Services reported $510.3M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Align Technology USD 363.97M 7.48M Dec/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Dentsply International USD 463M 17M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
ICU Medical USD 336.11M 4.69M Sep/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 7.97B 689M Dec/2025
Medtronic USD 3.52B 80M Sep/2025
Merit Medical Systems USD 197.75M 229K Sep/2025
Neogen USD 118.01M 3.79M Sep/2025
Quidel USD -756.9M 1.14B Sep/2025
Repligen USD 88.29M 2.93M Sep/2025
Solventum Corp USD 963M 23M Sep/2025
STAAR Surgical USD 16.86M 5.34M Sep/2025
Terumo JPY 127.97B 13.47B Sep/2025
West Pharmaceutical Services USD 510.3M 17.7M Sep/2025